Lavine Bekenstein Cancer Hospital

Boston, Massachusetts

A comprehensive wayfinding, architectural signage, and donor recognition program brings clarity and consistency to the new cancer hospital, supporting patient navigation while recognizing the generosity behind its development.

The Lavine Bekenstein Cancer Hospital at Dana-Farber is a new inpatient cancer hospital in Boston’s Longwood Medical Area, developed through a clinical collaboration between Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center (BIDMC). Designed by Payette, the 450,000-square-foot hospital will provide 300 inpatient beds across 10 patient floors, bringing specialized cancer treatment, clinical services, and research into a closely connected medical campus.

Designed around the needs of patients and families, the hospital will include advanced diagnostic imaging, radiation oncology, observation and support services, a pharmacy, café, and lobby garden. Patient and family amenities include dedicated parking, while improvements to the surrounding streetscape and Joslin Park will connect the new facility with its neighboring institutions. The building’s architecture incorporates natural light, warm materials, and landscaped spaces to create a welcoming environment for cancer care.

Construction is expected to be completed in 2030, with the hospital scheduled to welcome its first patients in 2031. The new facility represents a significant investment in Boston’s healthcare infrastructure, expanding access to specialized inpatient cancer care through the collaboration of two leading medical institutions.

Client: Dana-Farber Cancer Institute, Beth Israel Lahey Health Architect: Payette Landscape Architect: Michael Van Valkenburgh Associates